SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-22-008706
Filing Date
2022-12-30
Accepted
2022-12-30 16:05:37
Documents
1
Period of Report
2022-12-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4176
  Complete submission text file 0001683168-22-008706.txt   5729
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 299 PARK AVENUE SOUTH SUITE 90959 NEW YORK NY 10003
Business Address
Allen Daniel (Reporting) CIK: 0001736605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40699 | Film No.: 221502030